| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |